Benitec Biopharma (BNTC) stock: insider trades, news & valuation
Strong buyingShare price and insider trades
Benitec Biopharma insider trading at a glance (Oct 9, 2026): in the past 12 months, 3 insiders bought $22.4M and 0 sold $0 of BNTC stock on the open market.
Get emailed when insiders cluster-buy stocks like BNTC
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
BNTC insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | — | 0 |
| Q2 2026 | — | 0 | — | 0 |
| Q1 2026 | — | 0 | — | 0 |
| Q4 2025 | $22.4M | 14 | — | 0 |
Valuation, profit and volume
Summary
Over the past 12 months, 3 Benitec Biopharma Inc. insiders reported open-market purchases totaling $22.4M, while 0 insiders reported sales totaling $0. Among insiders with enough purchase history to measure, Suvretta Capital Management, Llc (Director) has the highest Insider Score at 100.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Dec 29SEC | Aaron CowenDirector | Buy | 65,8009,700,195 held (+1%) | $13.44 | $884K | -34.0% | — |
| Dec 29SEC | Aaron CowenDirector | Buy | 42,6009,620,075 held (+0%) | $12.85 | $547K | -31.0% | — |
| Dec 29SEC | Aaron CowenDirector | Buy | 14,3209,634,395 held (+0%) | $13.10 | $188K | -32.3% | — |
| Dec 29SEC | Aaron CowenDirector | Buy | 11,5871,848,156 held (+1%) | $13.44 | $156K | -34.0% | — |
| Dec 29SEC | Aaron CowenDirector | Buy | 7,4001,834,053 held (+0%) | $12.85 | $95K | -31.0% | — |
| Dec 29SEC | Aaron CowenDirector | Buy | 2,5161,836,569 held (+0%) | $13.10 | $33K | -32.3% | — |
| Dec 22SEC | Averill Madison Master Fund, Ltd.10% Owner | Buy | 16,6509,577,475 held (+0%) | $12.08 | $201K | -26.6% | — |
| Dec 22SEC | Averill Madison Master Fund, Ltd.10% Owner | Buy | 13,9509,560,825 held (+0%) | $11.48 | $160K | -22.7% | — |
| Dec 22SEC | Averill Madison Master Fund, Ltd.10% Owner | Buy | 8,7009,546,875 held (+0%) | $11.24 | $98K | -21.1% | — |
| Dec 22SEC | Averill Madison Master Fund, Ltd.10% Owner | Buy | 2,8921,826,653 held (+0%) | $12.08 | $35K | -26.6% | — |
| Dec 22SEC | Averill Madison Master Fund, Ltd.10% Owner | Buy | 2,4341,823,761 held (+0%) | $11.48 | $28K | -22.7% | — |
| Dec 22SEC | Averill Madison Master Fund, Ltd.10% Owner | Buy | 1,5151,821,327 held (+0%) | $11.24 | $17K | -21.1% | — |
| Nov 10SEC | Suvretta Capital Management, LlcDirector | Buy | 751,1111,819,812 held (+70%) | $13.50 | $10.1M | -34.3% | 100 |
| Nov 10SEC | Suvretta Capital Management, LlcDirector | Buy | 730,3709,538,175 held (+8%) | $13.50 | $9.9M | -34.3% | 100 |
Insiders at Benitec Biopharma Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Suvretta Capital Management, LlcDirector | $20.0M | — | Nov 10, 2025 | 100 |
| Aaron CowenDirector | $1.9M | — | Dec 29, 2025 | — |
| Averill Madison Master Fund, Ltd.10% Owner | $539K | — | Dec 22, 2025 | — |
BNTC stock: common questions
Are Benitec Biopharma Inc. insiders buying BNTC stock?
In the past 12 months, 3 insiders reported open-market purchases of BNTC worth $22.4M. The latest was Director Aaron Cowen bought $884K of BNTC at $13.44 — largest purchase by this insider in our records.
Are Benitec Biopharma Inc. insiders selling BNTC stock?
0 insiders reported sales worth $0 over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is BNTC's 52-week range?
Over the past year BNTC has traded between $8.75 and $16.52. It last closed at $8.87 on Oct 9, 2026.